Indian generic drugmakers launch a price war against Novo Nordisk’s GLP-1 brands, Ozempic and WeGovy.
Semaglutide belongs to the class of GLP-1 agonists, or glucagon-like peptide-1 receptor agonists. These medicines help ...
The landscape for weight-loss and diabetes treatment shifted dramatically over the weekend as at least six Indian ...